title: Neuroleptic malignant syndrome.
authors.forename: Shinji
authors.initials: S
authors.lastname: Yasugi
authors.forename: Vikas
authors.initials: V
authors.lastname: Garg
authors.forename: Greg
authors.initials: G
authors.lastname: Been
authors.forename: Penny
authors.initials: P
authors.lastname: Magoulas
mesh_terms: D000328:Adult; D000077582:Amisulpride; D018692:Antimanic Agents / Q000009:adverse effects / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001714:Bipolar Disorder / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D016651:Lithium Carbonate / Q000009:adverse effects / Q000627:therapeutic use; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis*; D012008:Recurrence; D012307:Risk Factors; D013469:Sulpiride / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D018692:Antimanic Agents; D014150:Antipsychotic Agents; D016651:Lithium Carbonate; D013469:Sulpiride; D000077582:Amisulpride